Regulation of Macrophage Efferocytosis by the CXCL10–CXCR3 Axis and CD36 in Acute Lung Injury
Frontiers in Bioscience-Landmark · 30.09.2026 · 31 (10)
DOI: 10.31083/fbl55164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 30.09.2026. Verfasst von Tianhao Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu …. Hauptthemen laut MEDLINE: Efferocytosis, Receptors, CXCR3, CD36 Antigens, Acute Lung Injury. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Research Project of Anhui Educational Committee, Longhu Talent Project of Bengbu Medical University, Hangzhou Health Science and Technology Plan (General Project, Class B).
Abstract (Originalsprache)
Background
Macrophage efferocytosis is the primary mechanism for clearing apoptotic cells (ACs) in vivo and is critical for maintaining tissue homeostasis. In acute lung injury (ALI), the C-X-C motif chemokine ligand 10 (CXCL10)–C-X-C motif chemokine receptor 3 (CXCR3) axis is upregulated and contributes significantly to pulmonary inflammation by regulating macrophage migration, invasion, polarization, and autophagy. However, whether this axis directly modulates macrophage efferocytosis remains unknown.
Methods
ALI models, both in vivo and in vitro, models were used to assess the impact of CXCL10–CXCR3 axis on macrophage efferocytosis. Using the CXCR3 antagonist AMG487, we assessed efferocytic capacity and examined the cluster of differentiation 36 (CD36)-ubiquitin-like 4A (UBL4A) interaction under inflammatory conditions, revealing that UBL4A-mediated CD36 degradation regulates efferocytosis.
Results
Efferocytosis was impaired in lung tissue and macrophages in ALI. Blocking the CXCL10–CXCR3 axis significantly enhanced efferocytosis in vivo. Mechanistically, inflammatory conditions promoted CD36 degradation by upregulating UBL4A. Treatment with AMG487 downregulated UBL4A expression, thereby preventing CD36 degradation and preserving efferocytosis in vivo, while attenuating UBL4A-mediated CD36 ubiquitination and degradation in vitro.
Conclusions
The CXCL10–CXCR3 axis negatively regulates macrophage efferocytosis during ALI through UBL4A-mediated CD36 degradation. Targeting this axis with AMG487 preserves efferocytosis by restoring CD36 levels, suggesting that this approach represents a potential therapeutic strategy for ALI and establishing a theoretical foundation for future targeted interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical University, 233030 Bengbu, Anhui, China.
- Linping Campus, The Department of Clinical Laboratory, The Second Affiliated Hospital of Zhejiang University School of Medicine, 311100 Hangzhou, Zhejiang, China.
- College of Life Science and Technology, Wuhan University of Bioengineering, 430415 Wuhan, Hubei, China.
Förderung
- Natural Science Research Project of Anhui Educational Committee
- Longhu Talent Project of Bengbu Medical University
- Hangzhou Health Science and Technology Plan (General Project, Class B)
Zitieren
APA
Ma, T., He, Y., Kang, H., Li, L., & Gu, W. (2026). Regulation of Macrophage Efferocytosis by the CXCL10–CXCR3 Axis and CD36 in Acute Lung Injury. Frontiers in Bioscience-Landmark, 31(10). https://doi.org/10.31083/fbl55164
Vancouver
Ma T, He Y, Kang H, Li L, Gu W. Regulation of Macrophage Efferocytosis by the CXCL10–CXCR3 Axis and CD36 in Acute Lung Injury. Frontiers in Bioscience-Landmark. 2026;31(10). doi:10.31083/fbl55164
BibTeX
@article{Ma2026,
author = {Ma, Tianhao and He, Yixuan and Kang, Hu and Li, Lexing and Gu, Wei},
title = {Regulation of Macrophage Efferocytosis by the CXCL10–CXCR3 Axis and CD36 in Acute Lung Injury},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {10},
doi = {10.31083/fbl55164}
}
EUVIMED